date,title,source
Oct-17-18,Novartis Q3 Earnings Preview,Benzinga
Oct-18-18,[$$] Novartis to Buy Cancer-Drug Maker Endocyte for $2.1 Billion,The Wall Street Journal
Oct-18-18,Endocyte's $2.1 Billion Deal Rewards Investors Who Stuck It Out,Bloomberg
Oct-18-18,Novartis to Buy Biopharmaceutical Company Endocyte for $2.1 Billion,GuruFocus.com
Oct-18-18,This tiny biotech spun a quick $2 billion from $12 million,MarketWatch
Oct-18-18,FDA snubs Novartis bid to repurpose inflammation drug for heart attacks,Reuters
Oct-18-18,Novartis Reports Positive Long-Term Data From Cosentyx Trials,Zacks
Oct-18-18,Novartis Gets Key Therapy -- For Almost 200 Times Its Last Price,Bloomberg
Oct-18-18,"Why Endocyte, Inc. Stock Is Soaring Today",Motley Fool
Oct-18-18,Novartis Secures Prostate Cancer Treatment With Endocyte Deal,TheStreet.com
Oct-18-18,Novartis To Buy Endocyte In $2.1B Deal,Benzinga
Oct-18-18,[$$] Novartis to Buy Cancer-Drug Maker Endocyte for $2.1 Billion,The Wall Street Journal
Oct-18-18,"The Daily Biotech Pulse: Novartis Buys Endocyte, Proteostasis Positive Cystic Fibrosis Trial, 2 IPOs",Benzinga
Oct-18-18,Endocyte stock pops 50% on $2.1 bln Novartis acquisition,MarketWatch
Oct-18-18,[$$] European Equities Market Talk Roundup,The Wall Street Journal
Oct-18-18,Novartis pushes deeper into nuclear medicine with $2.1 billion deal,Reuters
Oct-18-18,Novartis: 3Q Earnings Snapshot,Associated Press
Oct-18-18,Novartis pushes deeper into nuclear medicine with $2.1 bln deal,Reuters
Oct-18-18,[$$] European Corporate News Roundup,The Wall Street Journal
Oct-18-18,Endocyte Enters Into Agreement to be Acquired by Novartis for $24/Share,Benzinga
Oct-18-18,Novartis to buy cancer drugmaker Endocyte for $2.1 billion in cash,Reuters
Oct-18-18,Novartis to buy cancer drugmaker Endocyte for $2.1 billion in cash,Reuters
Oct-18-18,Novartis to buy cancer drugmaker Endocyte for $2.1 bln in cash,Reuters
Oct-18-18,"Novartis raises 2018 sales outlook as Entresto, Cosentyx accelerate",Reuters
Oct-18-18,Novartis to buy Endocyte for $2.1 billion in cash,Reuters
Oct-18-18,Novartis CEO: No fundamental changes to operations from B...,CNBC Videos
Oct-19-18,"The Daily Biotech Pulse: Novartis Positive Liver Drug Trials, Krytstal Prices Offering, LogicBio To Debut",Benzinga
Oct-19-18,Today's Research Reports on Trending Tickers: Pfizer and Novartis,ACCESSWIRE
Oct-19-18,This tiny biotech spun a quick $2 billion from $12 million,MarketWatch
Oct-22-18,"Novartis (NVS) Q3 Earnings In Line, Revenues Beat Estimates",Zacks
Oct-22-18,"BIIB, ALKS Q3 Earnings Due on Oct 23: What's in Store?",Zacks
Oct-22-18,This tiny biotech spun a quick $2 billion from $12 million,MarketWatch
Oct-23-18,"Biotech Stocks Earnings Lineup for Oct 24: VRTX, ALXN & SRPT",Zacks
Oct-25-18,"Bulls bet this financial name is set to bounce. Plus, the...",CNBC Videos
Oct-26-18,"Pharma Stock Roundup: MRK, BMY Q3 Earnings, Cancer Data Presentations at ESMO",Zacks
Oct-26-18,"The Daily Biotech Pulse: Gilead's Q2, Syndax Breast Cancer Drug Setback, Synergy Pharma On Brink Of Default",Benzinga
Oct-29-18,Drugmakers tout new medicines as eye disease battle intensifies,Reuters
Oct-29-18,"Novartis, Pfizer join forces on potentially lucrative fatty liver disease",Reuters
Oct-30-18,Aging Blockbusters Send Amgen Inc.'s Bottom Line Lower,Motley Fool
Oct-30-18,Incyte Corp (INCY) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Oct-31-18,GlaxoSmithKline plc (GSK) Q3 Earnings Conference Call Transcript,Motley Fool
Oct-31-18,Premier Bay Area biotech developer tees up next major project,American City Business Journals
Oct-31-18,"Aduro (ADRO) Q3 Loss Narrower Than Expected, Revenues Lag",Zacks
Oct-31-18,FDA approves Novartis' copy of AbbVie bestseller Humira,Reuters
Oct-31-18,"Amgen (AMGN) Beats on Earnings & Sales in Q3, Raises View",Zacks
Oct-31-18,"Glaxo (GSK) Beats Earnings Estimates in Q3, Revenue In-line",Zacks
Nov-01-18,Gene therapy: CHOP unveils $75M manufacturing facility (Photos),American City Business Journals
Nov-02-18,Novartis abandons effort for U.S. approval of biosimilar rituximab,Reuters
Nov-02-18,Novartis data at ASH and SABCS show strength of pipeline and portfolio in hematology and oncology,PR Newswire
Nov-02-18,"Conatus' (CNAT) Q3 Loss In Line, Revenues Lag Estimates",Zacks
Nov-05-18,"4 months after drug approval, Achaogen eyes fire sale",American City Business Journals
Nov-06-18,"Ionis Pharmaceuticals, Inc. (IONS) Q3 2018 Earnings Conference Call Transcript",Motley Fool
Nov-06-18,What Lies in Store for Ligand (LGND) This Earnings Season?,Zacks
Nov-07-18,This Rockville biotech is expanding to a new HQ. Here are the details.,American City Business Journals
Nov-07-18,Amgen (AMGN) Counts on New Drugs Amid Rising Biosimilar Woes,Zacks
Nov-08-18,Novartis division Sandoz recalls one lot of blood pressure drug,Reuters
Nov-08-18,Ligand Pharmaceuticals Inc (LGND) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Nov-09-18,"Ligand (LGND) Beats on Q3 Earnings & Revenues, Raises View",Zacks
Nov-12-18,Tilray (TLRY) to Report Q3 Earnings: What's in the Cards?,Zacks
Nov-12-18,These Biopharmas Could Cure Genetic Diseases  At $5 Million Apiece,Investor's Business Daily
Nov-14-18,Migraine-Focused Biotech Has A Headache On Quarterly Losses,Investor's Business Daily
Nov-14-18,Novartis AG (NVS) Not Doing Enough to Attract Smart Money,Insider Monkey
Nov-15-18,Novartis launches third-to-market Remicade copy in Germany,Reuters
Nov-15-18,"The Zacks Analyst Blog Highlights: Chevron, Novartis, Qualcomm, TJX and Deere",Zacks
Nov-15-18,"Novartis 'completely committed' to Sandoz, has no split-off plan",Reuters
Nov-15-18,"Novartis says 'completely committed' to Sandoz, not planning split-off",Reuters
Nov-16-18,Novartis' blood disorder drug gets FDA approval for expanded use,Reuters
Nov-16-18,Alphabet unit halts glucose-detecting contact lens project,Reuters
Nov-19-18,[$$] Novartis CEO Bets on Cutting-Edge Science to Remake Drug Giant,The Wall Street Journal
Nov-20-18,Gilead's Vemlidy Gets Approval in China for HBV Infection,Zacks
Nov-20-18,CYRX: Q3 Another Very Strong Quarter With New Records in Several Categories. Operating Leverage Continues To Solidify,Zacks Small Cap Research
Nov-20-18,"The Daily Biotech Pulse: Denali's Positive Results, Novartis' Substance Abuse Therapy Launch, Medtronic Earnings",Benzinga
Nov-21-18,This Highly Rated Pharma Giant Is More Than Just A Diabetes Player,Investor's Business Daily
Nov-23-18,US benefits manager baulks after Novartis values gene therapy at $4-5 mln,Reuters
Nov-23-18,"Pharma Stock Roundup: Cancer Approvals for PFE & ABBV, CHMP Nod for Several Drugs",Zacks
Nov-23-18,Novartis's pricing might be tested with costly eye therapy,Reuters
Nov-23-18,Novartis Gets Approval for Gene Therapy Luxturna in Europe,Zacks
Nov-23-18,U.S. benefits manager baulks after Novartis values gene therapy at $4-5 million,Reuters
Nov-26-18,Spark Therapeutics' Luxturna Gets EU Approval for Vision Loss,Zacks
Nov-26-18,"Health Care Digest: Genentech's blood cancer win, a boost for Gilead's HIV PrEP and a tiny IPO swings at antibiotics",American City Business Journals
Nov-26-18,Novartis CEO: 4 factors can help the industry price and pay for lifesaving cell and gene therapies,CNBC
Nov-26-18,4 Reasons Why Lilly is Up More Than 30% This Year So Far,Zacks
Nov-26-18,European approval of Spark Therapeutics' gene therapy triggers $25M payment,American City Business Journals
Nov-27-18,Roche buys U.S. biotech Jecure in race for liver disease drugs,Reuters
Nov-27-18,Novartis's Alcon sees myopia epidemic driving sales growth,Reuters
Nov-27-18,3 Reasons Why Glaxo (GSK) Stock is Up This Year So Far,Zacks
Nov-28-18,Novartis (NVS) Receives EC Approval for Neulasta Biosimilar,Zacks
Nov-28-18,Celgene & Bluebird's CAR T Therapy Study Completes Enrollment,Zacks
Nov-28-18,Novartis' Biosimilar to Amgen's Neulasta Approved in Europe,GuruFocus.com
Nov-28-18,Novartis joins rush of science companies moving to White City,Evening Standard
Nov-28-18,"Glaxo's Horlicks Sale Bid Heats Up, Nestle, Unilever Close In",Zacks
Nov-29-18,Teva's Rituxan Biosimilar Gets FDA Nod in Non-Hodgkin Lymphoma,Zacks
Nov-29-18,Roche (RHHBY) to Acquire Jecure and Enter the NASH Space,Zacks
Nov-29-18,4 Big Pharma Stocks to Add to Your Portfolio in December,Zacks
Nov-30-18,Pfizer Stock Edges Into Buy Zone On AbbVie Deal For Humira Biosimilar,Investor's Business Daily
Nov-30-18,This Biotech Stock Could Launch Its First CRISPR Drug In 2022,Investor's Business Daily
Nov-30-18,Novartis' Gilenya Approved in EU for Expanded Population,Zacks
Nov-30-18,Novartis CEO Has One New Breakthrough Drug: It Costs $4 Million,Meredith Videos
Dec-03-18,UPDATE 1-High-cost Gilead cell therapy proves durable for some lymphoma patients,Reuters
Dec-03-18,Novartis SMA treatment could get FDA approval in May,Reuters
Dec-04-18,Incyte (INCY) Announces Positive Data on Jakafi for GVHD,Zacks
Dec-04-18,Gilead (GILD) Announces Data on CAR T Therapy Candidate,Zacks
Dec-04-18,FDA Accepts BLA & Gives Priority Review to Novartis' AVXS-101,Zacks
Dec-04-18,Global Blood Therapeutics' Voxelotor on Faster Approval Path,Zacks
Dec-04-18,Glaxo to Sell India's Popular Horlicks Brand to Unilever,Zacks
Dec-04-18,Novartis's new treatment for hives outperforms Xolair in trials,Reuters
Dec-06-18,Novartis to launch Adamis' EpiPen rival in U.S. next year,Reuters
Dec-06-18,Conatus' Emricasan Misses Primary Endpoint in Mid-Stage Study,Zacks
Dec-06-18,Roche's Kadcyla Halves Death Risk in Breast Cancer Study,Zacks
Dec-10-18,"Amgen (AMGN) Continues to Reward Shareholders, Ups Dividend",Zacks
Dec-11-18,Teva (TEVA) Stock Poised to Record Big Gains in 2019?,Zacks
Dec-11-18,"The Daily Biotech Pulse: Management Change At Merck, Jazz Buyback, Arrowhead Earnings",Benzinga
Dec-12-18,J&J says its psoriasis drug superior to Novartis treatment in study,Reuters
Dec-12-18,J&J says its psoriasis drug superior to Novartis' in study,Reuters
Dec-13-18,J&J's Tremfya Beats Novartis' Cosentyx in Head-to-Head Study,Zacks
Dec-13-18,"The Daily Biotech Pulse: Vivus Extends Supply Deal With Sandoz, Applied Genetic Snaps Ties With Biogen",Benzinga
Dec-14-18,Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?,Zacks
Dec-14-18,"Pharma Stock Roundup: AZN, RHHBY Cancer Drugs, LLY, BMY New Deals in Focus",Zacks
Dec-14-18,Today's Research Reports on Trending Tickers: Bristol-Myers Squibb and Novartis,ACCESSWIRE
Dec-17-18,Roche's SMA Candidate Risdiplam Gets PRIME Designation in EU,Zacks
Dec-17-18,Incyte (INCY) Collaborates with Innovent for 3 Candidates,Zacks
Dec-18-18,Tilray shares soar on deal with Novartis. Here's what it ...,CNBC Videos
Dec-18-18,Tilray Jumps After Canadian Pot Stock Signs Deal With Novartis,Investor's Business Daily
Dec-18-18,"What's In Store for GE in 2019? & Tuesday's Trending Stocks: TLRY, JNJ, ORCL",Zacks
Dec-18-18,Why Tilray Is Jumping Today,Motley Fool
Dec-18-18,Tilray Partners with Novartis in Big Pharmas First Deal of Its Kind with Big Marijuana,Barrons.com
Dec-18-18,Tilray Shares Surge on Novartis Distribution Deal,TheStreet.com
Dec-18-18,Tilray Shares Jump On The Back Of Novartis Partnership,Benzinga
Dec-18-18,Puma Biotech's Nerlynx Ups Survival in Third-Line Breast Cancer,Zacks
Dec-18-18,Tilray partners with Novartis in Big Pharmas first deal of its kind with Big Marijuana,MarketWatch
Dec-18-18,Teva Reports Positive Top-Line Data for Migraine Candidate,Zacks
Dec-18-18,"Alkermes, Biogen Submit NDA to FDA for Multiple Sclerosis Drug",Zacks
Dec-18-18,Cannabis company Tilray shares jump 11% after announcing deal with Swiss drugmaker Novartis,CNBC
Dec-18-18,"J&J Okays $5B Stock Buyback Plan, Stock Remains Stressed",Zacks
Dec-19-18,Major pharma companies plan to raise drug prices in January: report,MarketWatch
Dec-19-18,Exclusive: Big Pharma returning to U.S. price hikes in January after pause,Reuters
Dec-19-18,Exclusive: Big Pharma returning to U.S. price hikes in January after pause,Reuters
Dec-19-18,Tilray shares surge after announcing $100 million deal with AB InBev to study cannabis-based beverages,CNBC
Dec-19-18,Aduro Stock Surges on STING Activator Deal With Eli Lilly,Zacks
Dec-19-18,Tilray Stock Up on Medical Cannabis Collaboration With Sandoz,Zacks
Dec-19-18,"Company News For Dec 19, 2018",Zacks
Dec-19-18,"Glaxo, Pfizer to Merge Consumer Health Units, Form New JV",Zacks
Dec-19-18,"Novartis, China's Gan & Lee push into insulin amid diabetes epidemic",Reuters
Dec-19-18,Novartis links with China's Gan & Lee in global insulin push,Reuters
Dec-20-18,U.S body says gene therapy may be more cost effective for spinal muscular atrophy,Reuters
Dec-20-18,"Commentary: GSK, Pfizer and GE shift away from diversification in latest round of health-care deals",CNBC
Dec-20-18,Novartis oncology boss Barrett makes quick exit,Reuters
Dec-20-18,"The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum",Benzinga
Dec-20-18,Is Tilray Stock a Must-Buy Following New Partnership?,InvestorPlace
Dec-20-18,Novartis appoints Susanne Schaffert to lead oncology business,Reuters
Dec-21-18,Why Gene Therapy Is More Cost Effective Than Biogen's Approved Drug,Investor's Business Daily
Dec-21-18,Novartis (NVS) Offers to Buy French Gene Therapy Manufacturer,Zacks
Dec-24-18,Jazz (JAZZ) Falls as Sleep Drug Gets Extended Review From FDA,Zacks
Dec-27-18,Teva Stock Rises on Patent Settlement With Neos Therapeutics,Zacks
Dec-27-18,"Forget J&J, Buy These 3 Big Drug Stocks Instead in 2019",Zacks
Dec-28-18,Conatus (CNAT) Focuses on Developing NASH Candidate Emricasan,Zacks
Dec-31-18,Novartis (NVS) Benefits From New Drugs & Key Acquisitions,Zacks
Jan-03-19,Verily lines up $1 billion investment,American City Business Journals
Jan-03-19,Bristol-Myers' (BMY) Sprycel Gets FDA Nod for Label Expansion,Zacks
Jan-03-19,Ironwood/Allergan Settle Linzess Patent Litigation With Mylan,Zacks
Jan-03-19,Will Pfizer's (PFE) Stock Keep Up the Momentum in 2019?,Zacks
Jan-04-19,Tilray Gains More Than 200%: Is There More Scope for Growth?,Zacks
Jan-04-19,These Stocks Pop After FDA Expedites Review Of Gene-Editing Therapy,Investor's Business Daily
Jan-07-19,Cramer Remix: This chipmaker could have another bad quarterbut it's worth buying now,CNBC
Jan-07-19,Novartis CEO on chasing cures over profitable treatments,CNBC Videos
Jan-07-19,"Novartis CEO talks chasing cures over profitable treatments, says they will 'ultimately' be valued",CNBC
Jan-08-19,Novartis Stock Is Poised to Rise Another 15% From Here,TheStreet.com
Jan-08-19,"The Daily Biotech Pulse: Amgen Slashes Cholesterol Drug Device Prices By 60%, Takeda Completes Shire Purchase",Benzinga
Jan-09-19,Canopy Growth Moves to Key Resistance,Investopedia
Jan-09-19,Novartis' Crizanlizumab Gets Breakthrough Therapy Status,Zacks
Jan-10-19,Novartis migraine drug not cost effective - U.K. price watchdog,Reuters
Jan-11-19,NASH Space in Focus in 2019 as Firms Look to Diversify,Zacks
Jan-11-19,Will Tilrays Dealmaking Lift Tilray Stock in 2019?,InvestorPlace
Jan-11-19,Puma Biotech (PBYI) Down More Than 40% in 90 Days: Here's Why,Zacks
Jan-11-19,"Pharma Stock Roundup: Lilly to Buy Loxo for $8B, M&A in Focus at JP Morgan Meet",Zacks
Jan-14-19,Tilray Shares Rally as Investor Plans Not to Sell Shares,Zacks
Jan-15-19,Here's How The Government Shutdown Will Affect These Medical Stocks,Investor's Business Daily
Jan-16-19,Adamis stock surges on release of EpiPen alternative,MarketWatch
Jan-16-19,Intrexon Signs Licensing Agreement with Next Green Wave,Zacks
Jan-16-19,"Tilray Teams Up With Authentic Brands, Stock Down on Sell-Off",Zacks
Jan-16-19,6 Reasons Why You Should Buy Eli Lilly (LLY) Stock in 2019,Zacks
Jan-17-19,NVS or AZN: Which Is the Better Value Stock Right Now?,Zacks
Jan-22-19,Alnylam &amp; Medison Partner to Market RNAi Products in Israel,Zacks
Jan-23-19,Why Tilray Stock Can Still Set Itself Apart From the Crowd,InvestorPlace
Jan-24-19,Is a Surprise in the Cards for Novartis (NVS) in Q4 Earnings?,Zacks
Jan-25-19,Novartis urges Britain to secure drug supplies before Brexit,Reuters
Jan-28-19,How Novartis Could Throw A Haymaker  And Slam Amgen's Sales,Investor's Business Daily
Jan-28-19,Amgen (AMGN) to Report Q4 Earnings: What's in the Cards?,Zacks
Jan-29-19,"Allergan (AGN) Q4 Earnings Beat Estimates, 2019 View Tepid",Zacks
Jan-30-19,"Despite Raising Prices, Big Pharma Is Selling Drugs for Less",The Wall Street Journal
Jan-30-19,"Novartis Slides On Earnings Lag, But Sees 10 New Blockbusters By 2020",Investor's Business Daily
Jan-30-19,Novartis CEO sees 'further conversation' on Sandoz future in 18 months,Reuters
Jan-30-19,Novartis 2019 growth outlook leaves investors wanting more,Reuters
Jan-30-19,"The Daily Biotech Pulse: Roche Scraps Alzheimer's Disease Trials, Amgen Issues Weak Guidance",Benzinga
Jan-30-19,A Cure for Cancer Next Year? The Stock Market Says Don't Believe the Hype,Motley Fool
Jan-30-19,Novartis: 4Q Earnings Snapshot,Associated Press
Jan-30-19,Novartis Misses Earnings and Sales Estimates in Q4,Zacks
Jan-30-19,[$$] Novartis's Bet on Higher-Value Drugs Pays Off,The Wall Street Journal
Jan-30-19,[$$] Novartis forecasts mid-single digit sales growth in 2019,Financial Times
Jan-30-19,"Novartis earnings narrowly miss expectations, shares down 2%",CNBC
Jan-31-19,"Novartis Posts Earnings, Revenue Miss",GuruFocus.com
Jan-31-19,"Novartis (NVS) Q4 Earnings Miss Estimates, Revenues Up Y/Y",Zacks
Feb-01-19,Mylan's Generic Version of Advair Diskus Wins FDA Approval,Zacks
Feb-01-19,Roche (RHHBY) 2018 Sales Up on Solid New Drugs Performance,Zacks
Feb-01-19,Gene Therapy: Novartis Under The Microscope With Novel Treatment,Investor's Business Daily
Feb-01-19,"Pharma Stock Roundup: Q4 Earnings, Pipeline Updates at PFE, RHHBY",Zacks
Feb-04-19,Teva Gains Positive CHMP Opinion for Migraine Drug Ajovy,Zacks
Feb-04-19,What's in the Cards for Glaxo (GSK) This Earnings Season?,Zacks
Feb-04-19,[$$] Novartis Backs Lutathera Pricing After Price-Gouging Accusations,The Wall Street Journal
Feb-05-19,Array Biopharma Inc (ARRY) Q2 2019 Earnings Conference Call Transcript,Motley Fool
Feb-05-19,Should You Buy Cronos Group Stock Right Now?,InvestorPlace
Feb-05-19,Novartis's Alcon eye-care unit to enter Swiss index after spin off,Reuters
Feb-05-19,Roche Submits sBLA to FDA for Label Expansion of Kadcyla,Zacks
Feb-05-19,"Gilead (GILD) Q4 Earnings Miss Estimates, Revenues Beat",Zacks
Feb-06-19,Novartis CEO says U.S. rebate plan will return cash to patients,Reuters
Feb-06-19,Novartis CEO says U.S. rebate plan will return cash to patients,Reuters
Feb-06-19,Glaxo Inks Deal With Merck KGaA to Co-Develop Cancer Candidate,Zacks
Feb-07-19,"Glaxo (GSK) Beats on Q4 Earnings, to Focus on Oncology in '19",Zacks
Feb-07-19,Novartis CEO lauds Trump administration plan to overhaul rebates,Reuters
Feb-08-19,Tilray (TLRY) to Report Q4 Earnings: What's in the Cards?,Zacks
Feb-08-19,Incyte Down as FDA Extends Review Period of Jakafi for GVHD,Zacks
Feb-08-19,"Ligand (LGND) Beats on Q4 Earnings &amp; Sales, Raises '19 View",Zacks
Feb-11-19,Is a Disappointment in Store for Incyte (INCY) Q4 Earnings?,Zacks
Feb-12-19,Aduro Initiates Dosing in Phase I Melanoma Study on ADU-S100,Zacks
Feb-13-19,Conatus (CNAT) Completes Enrollment in Phase II NASH Study,Zacks
Feb-13-19,Key Takeaways from Eli Lilly's (LLY) Q4 Earnings Report,Zacks
Feb-13-19,Clinigen agrees to buy U.S. rights to Novartis' cancer drug Proleukin,Reuters
Feb-13-19,"Top Research Reports for ExxonMobil, Merck & Danaher",Zacks
Feb-13-19,Clinigen agrees to buy U.S. rights to Novartis' cancer drug Proleukin,Reuters
Feb-14-19,"Incyte (INCY) Q4 Earnings Miss Estimates, Revenues Beat",Zacks
Feb-14-19,"The Zacks Analyst Blog Highlights: ExxonMobil, Merck, Danaher, Novartis and Expedia",Zacks
Feb-14-19,"The Daily Biotech Pulse: Vanda Q4 Results, Inovio Debt Offering, Caladrius Diabetes Drug Flunks Mid-Stage Trial",Benzinga
Feb-14-19,[$$] J&J and Novartis back cancer geneticists immunotherapy start-up,Financial Times
Feb-15-19,U.S. Medicare plans to track CAR-T cancer therapy outcomes,Reuters
Feb-15-19,Biogen Inc. -- Moody's announces completion of a periodic review of ratings of Biogen Inc.,Moody's
Feb-15-19,Medicare would cover CAR-T therapies under new CMS proposal,MarketWatch
Feb-19-19,Roche's (RHHBY) BLA for Lymphoma Drug Gets Priority Review,Zacks
Feb-20-19,AbbVie's RA Candidate Upadacitinib Gets FDA Priority Review,Zacks
Feb-20-19,"The Daily Biotech Pulse: Teva Settles With FTC, Setback For Merck In Liver Cancer Trial, Sienna Biopharma Offering",Benzinga
Feb-21-19,Biogen stock down 1.2% after downgrade by Stifel,MarketWatch
Feb-22-19,"Novartis gene therapy would be cost effective up to $900,000 -U.S. group",Reuters
Feb-22-19,"Novartis gene therapy is cost effective at up to $900,000 -U.S. group",Reuters
Feb-25-19,Why Investors Should Cash Out Of This Soaring Biotech Stock,Barrons.com
Feb-25-19,Novartis aims to pump up cardio business with Ionis deal,Reuters
Feb-25-19,Novartis In-Licenses Rights to Heart Candidate From Ionis,Zacks
Feb-25-19,Roche (RHHBY) to Acquire Spark Therapeutics for $4.8 Billion,Zacks
Feb-25-19,Roche bets $4.3 bln on Spark in gene therapy move,Reuters Videos
Feb-25-19,"Detailed Research: Economic Perspectives on Novartis AG, Proteostasis Therapeutics, Williams-Sonoma, Magna International, YRC Worldwide, and Delek Logistics Partners  What Drives Growth in Today's Competitive Landscape",GlobeNewswire
Feb-25-19,Novartis licenses rights to RNA-targeting cardio drug from Ionis,Reuters
Feb-26-19,Biotech ETFs Jump on Roche-Spark Deal,Zacks
Feb-26-19,Alkermes' (ALKS) and Biogen's NDA for BIIB098 Accepted by FDA,Zacks
Feb-27-19,"Trump ex-lawyer Cohen: drugmaker Novartis wanted him to lobby, he refused",Reuters
Feb-27-19,"Trump ex-lawyer Cohen: drugmaker Novartis wanted him to lobby, he refused",Reuters
Feb-27-19,"Trump's ex-lawyer Cohen: drugmaker Novartis wanted him to lobby, but he declined",Reuters
Feb-27-19,"Ophthotech's (OPHT) Q4 Loss Wider, Gene Therapy in Focus",Zacks
Feb-28-19,Aduro (ADRO) Q4 Earnings and Revenues Fall Shy of Estimates,Zacks
Feb-28-19,Novartis faces shareholder criticism over drug prices at AGM,Reuters
Feb-28-19,Novartis faces shareholder criticism over drug prices at AGM,Reuters
Mar-04-19,Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates,Benzinga
